M. Dimartino et al., ANTIARTHRITIC ACTIVITY OF HYDROXAMIC ACID-BASED PSEUDOPEPTIDE INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA PROCESSING, Inflammation research, 46(6), 1997, pp. 211-215
Objective and Design: The effects of two hydroxamate inhibitors of met
alloproteinase and tumor necrosis factor alpha (TNF alpha) processing
on endotoxin-induced plasma TNF alpha and arthritic lesions in adjuvan
t-induced arthritic (AA) rats were determined. Material and Treatment:
BB-1101 and BE-1433 were administered orally twice daily to AA Lewis
rats with an established disease (days 13 to 22). AA rats (day 16) or
normal rats were injected with bacterial endotoxin and plasma levels o
f TNF alpha were also determined. Methods: Hindpaw swelling was measur
ed plethysmogra phically. Bone degradation was determined by radiograp
hy and bone mineral densitometry. TNF alpha was quantified using a san
dwich ELISA. Results: The hydroxamic-acid pseudopeptides inhibited pla
sma TNF alpha levels in vivo and significantly reduced swelling and bo
ne degradation of the tibiotarsal joints of AA rats in the range of 10
-50 mg/kg given orally (p < 0.01 by Student's t-test). Conclusions: Th
us, these novel compounds offer a new disease-modifying therapy for ar
thritis and the results also suggest that inhibition of TNF alpha prod
uction may contribute, at least in part, to their anti-arthritic activ
ity.